Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Doron Feinsilber MD

Instructor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology


Publications

  • Polyparaneoplastic Manifestations of Malignant Thymoma: A Unique Case of Myasthenia, Autoimmune Hepatitis, Pure Red Cell Aplasia, and Keratoconjunctivitis Sicca. (Feinsilber D, Mears KA, Pettiford BL) Cureus 2017 Jun 20;9(6):e1374 PMID: 28744421 PMCID: PMC5519314 07/27/2017
  • Polyparaneoplastic Manifestations of Malignant Thymoma: A Unique Case of Myasthenia, Autoimmune Hepatitis, Pure Red Cell Aplasia, and Keratoconjunctivitis Sicca (Doron Feinsilber, Katrina A. Mears, Brian L. Pettiford ) Cureus Journal of Medicine Feinsilber D, Mears K A, Pettiford B L (June 20, 2017) Polyparaneoplastic Manifestations of Malignant Thymoma: A Unique Case of Myasthenia, Autoimmune Hepatitis, Pure Red Cell Aplasia, and Keratoconjunctivitis Sicca. Cureus 9(6): e1374. doi:10.7759/cureus.1374 06/20/2017
  • Evaluation of relative thrombocytopenia, identification of neuropathy, and bleeding risk secondary to utilization of neuromodulating agents in multiple myeloma patients receiving autologous stem cell transplant treated with melphalan, bortezomib, and lenalidomide. Journal of Clinical Oncology DOI: 10.1200/jco.2016.34.7_suppl.212 Journal of Clinical Oncology 34, no. 7_suppl (March 2016) 212-212. 03/10/2016
  • The Role of Dose-Dense Neo Adjuvant Triple H Therapy, Hugs, Humor and Humility: Palliative Medicine, Oncology, and the Human Spirit – A Clinician’s Journey (Doron Feinsilber, M.D.) Palliative Medicine and Hospice Care Feinsilber D. The role of dose-dense neo adjuvant triple H therapy, hugs, humor, and humility: palliative medi- cine, oncology, and the human spirit - a clinician’s journey. Palliat Med Hosp Care Open J. 2015; 1(2): 50- 52. 07/29/2015
  • In-vitro synergistic cellular proliferation inhibition in pancreatic cancer cells Su86 and Mia-PaCa-2 with fluvastatin and nab-paclitaxel. Journal of Clinical Oncology 10.1200/jco.2015.33.15_suppl.e15245 Journal of Clinical Oncology 33, no. 15_suppl 05/10/2015
  • In-vitro synergistic cellular proliferation inhibition in pancreatic cancer cells Su86 and Mia-PaCa-2 with fluvastatin and nab-paclitaxel. Journal of Clinical Oncology 10.1200/jco.2015.33.3_suppl.331 Journal of Clinical Oncology 33, no. 3_suppl (January 2015) 331-331. 01/05/2015
  • Last update: 08/12/2017
    jenkins-FCD Prod-141 f776ee82366dc5656a368d51cce32734d2f9b9a0